4Matthieu L, De-Doncker P, Cauwenbergh G,et al. Itraconazole penetrates the nail via the nail matrix and the nail bed an investigation in onychomycosis [J]. Clin Exp Dermatol,1991, 16(5): 374-376.
5Elewski BE. Onychomycosis: pathogenesis, diagnosis, and management[J]. Clin Microbiol Rev, 1998,11 (3): 415-429.
6Roseeuw D,De-Doncker P. New approaches to the treatment of onychomycosis[J]. J Am Acad Dermatol , 1993,29 (1):S45-S50.
7De-Doncker P, Decroix J, Pierard GE, et al. Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmaco dynamic investigation of monthy cycles of 1 week pulse therapy with itraconazole[J]. Arch Dermatol, 1996,132 (1):34-41.
8Doncker PD,Pierard GE. Acquired nail beading in patients re ceiving itraconazole-an indicator of faster nail growth? A stud y using optical profilometry[J]. Clin Exp Dermatol, 1994,19(5):404-406.
9Willemsen M, De-Doncker P, Willems J,et al. Posttreatment itraconazole levels in the nail. New implications for treatment in onychornycosis[J]. J Am Acad Dermatol, 1992,26 (5 Pt 1): 731-735.
10Koumantaki E,Georgala S,Rallis E,et al.Microsporum canis tinea capitis in an 8-month-old infant successfully treated with 2 weekly pulses of oral itraconazole.Pediatr Dermatol,2001,18:60.
